<?xml version="1.0" encoding="UTF-8"?>
<ref id="cam41690-bib-0025">
 <label>25</label>
 <mixed-citation publication-type="book" id="cam41690-cit-0025">
  <string-name>
   <surname>Norman</surname>
   <given-names>TR</given-names>
  </string-name>. 
  <chapter-title>Agomelatine, melatonin and depression</chapter-title> In: 
  <person-group person-group-type="editor">
   <name>
    <surname>López‐Muñoz</surname>
    <given-names>F</given-names>
   </name>
  </person-group>, 
  <person-group person-group-type="editor">
   <name>
    <surname>Srinivasan</surname>
    <given-names>V</given-names>
   </name>
  </person-group>, 
  <person-group person-group-type="editor">
   <name>
    <surname>de Berardis</surname>
    <given-names>D</given-names>
   </name>
  </person-group>, et al., eds. 
  <source xml:lang="en">Melatonin, neuroprotective agents and antidepressant therapy</source>. 
  <publisher-loc>New Delhi, India</publisher-loc>: 
  <publisher-name>Springer</publisher-name>; 
  <year>2016</year>:
  <fpage>229</fpage>‐
  <lpage>247</lpage>.
 </mixed-citation>
</ref>
